Charles Fuchs

Charles Fuchs has extensive work experience in the field of oncology and hematology drug development. Charles currently holds the role of Senior Vice President - Global Head of Oncology & Hematology Drug Development at Genentech and Roche. Prior to this, Charles co-founded EvolveImmune Therapeutics and served on its Board of Directors. Charles was also a member of the Board of Directors at CytomX Therapeutics. Charles held the position of Director at Yale Cancer Ctr and served as the Physician-in-Chief at Smilow Cancer Hospital. Charles began their career at Dana-Farber Cancer Institute, where they worked as the Director of the Center for Gastrointestinal Cancer from 1989 to 2016.

Charles Fuchs received their Bachelor's degree in Biochemistry from the University of Pennsylvania in 1982. Charles then went on to attend Harvard Medical School, where they obtained their Doctor of Medicine (MD) degree in 1986. Following this, they pursued further education and earned a Masters of Public Health from the Harvard T.H. Chan School of Public Health in 1994.